Beam Therapeutics BEAM
NASDAQ BEAM
$25.81 +0.66 (+2.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Beam Therapeutics (BEAM) Gains (Losses) on Sale of Assets & Investments (2019 - 2026)

Updated

Analysis

Beam Therapeutics (BEAM) Gains (Losses) on Sale of Assets & Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Beam Therapeutics 2.60 Bn -2.05 Bn - -1.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1.02 Mn
Jun 30, 2026 455,000.00
Mar 31, 2026 16,000.00
Dec 31, 2025 -3.33 Mn
Sep 30, 2025 4.94 Mn
Jun 30, 2025 4.42 Mn
Mar 31, 2025 -2.08 Mn
Dec 31, 2024 -1.09 Mn
Sep 30, 2024 -2.06 Mn
Jun 30, 2024 -7.59 Mn
Mar 31, 2024 -3.35 Mn
Dec 31, 2023 -722,000.00
Sep 30, 2023 -11.22 Mn
Jun 30, 2023 6.15 Mn
Mar 31, 2023 -12.80 Mn
Dec 31, 2022 21.58 Mn
Sep 30, 2022 10.43 Mn
Jun 30, 2022 -4.12 Mn
Mar 31, 2022 -7.69 Mn
Dec 31, 2021 -4.27 Mn
API Access

Beam Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BEAM&period=max&api_key=YOUR_API_KEY